Lexaria Bioscience Corp (LEXX) — Cash Flow Quality Index
Latest as of February 2021:
-2.19x
Lexaria Bioscience Corp (LEXX) has a Cash Flow Quality Index of -2.19x as of February 2021. Operating cash flow of $-911.25K is below net income of $415.19K, suggesting accrual-heavy earnings not yet converted to cash. Explore Lexaria Bioscience Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-2.19x
Operating CF / Net Income
Operating Cash Flow
$-911.25K
USD
Net Income
$415.19K
USD
Data as of
Feb 2021
Most recent filing
Annual Cash Flow Quality Index for Lexaria Bioscience Corp (None–None)
Year-by-year earnings quality comparison for Lexaria Bioscience Corp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.